Aveanna Healthcare Holdings Inc. (AVAH) saw its stock price soar 10.64% during intraday trading on Thursday, marking a significant upward movement for the healthcare services provider.

The surge follows the company's release of robust first-quarter financial results, which exceeded analyst expectations. Aveanna reported Q1 revenue of $647.9 million, beating the IBES estimate of $613.2 million, while adjusted earnings per share came in at $0.18, surpassing the $0.13 estimate. Net income for the quarter was $41.7 million, a substantial increase from $5.2 million in the prior-year period, and adjusted EBITDA grew 25.2% year-over-year to $84.4 million.

Adding to the positive sentiment, the company raised its full-year 2026 guidance, increasing its revenue outlook to a range of $2.56-$2.58 billion from $2.54-$2.56 billion and boosting its adjusted EBITDA guidance to $328-$332 million from $318-$322 million. This upward revision signals management's confidence in the company's continued strong performance throughout the fiscal year.